Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bonertz

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Opinion in Allergy and Clinical Immunology|August 27, 2019
Manufacturing and quality assessment of allergenic extracts for immunotherapy: state of the artAndreas Bonertz, Vera Mahler, Stefan Vieths
Current Opinion in Oncology|September 23, 2009
Current developments with peptide-based human tumor vaccinesKhashayarsha Khazaie, Andreas Bonertz, Philipp Beckhove
Current Allergy and Asthma Reports|May 10, 2021
Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food AllergyLisa Englert, Vera Mahler, Andreas Bonertz
Current Opinion in Allergy and Clinical Immunology|August 23, 2020
New guidance on the regulation of allergen products: key aspects and outcomesAndreas Bonertz, Vera Mahler, Stefan Vieths
Allergy|December 29, 2022
Introduction of General Chapters on standard methods for allergen quantification in the European PharmacopoeiaJulia Zimmer, Andreas Bonertz, Susanne Kaul, et al.
British Journal of Clinical Pharmacology|March 25, 2025
European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populationsAndreas Bonertz, Catherine Drai, Thomas Castelnovo, et al.
Allergy|March 1, 2024
Quality control of allergen products with mass spectrometry part I: Positioning within the EU regulatory frameworkJelena Spiric, Thomas Schulenborg, Thomas Holzhauser, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2022
A regulator's view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensureAndreas Bonertz, Anubha Tripathi, Julia Zimmer, et al.
Journal of the National Cancer Institute|July 27, 2007
Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinomaDaniel Nummer, Elisabeth Suri-Payer, Hubertus Schmitz-Winnenthal, et al.
Allergologie Select|December 25, 2023
Allergen-specific immunotherapy and evidence: A European regulatory perspectiveDetlef Bartel, Andreas Bonertz, Diana Hartenstein, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Allergy and Clinical Immunology|August 27, 2019
Manufacturing and quality assessment of allergenic extracts for immunotherapy: state of the artAndreas Bonertz, Vera Mahler, Stefan Vieths
Current Opinion in Oncology|September 23, 2009
Current developments with peptide-based human tumor vaccinesKhashayarsha Khazaie, Andreas Bonertz, Philipp Beckhove
Current Allergy and Asthma Reports|May 10, 2021
Regulatory Requirements for the Quality of Allergen Products for Allergen Immunotherapy of Food AllergyLisa Englert, Vera Mahler, Andreas Bonertz
Current Opinion in Allergy and Clinical Immunology|August 23, 2020
New guidance on the regulation of allergen products: key aspects and outcomesAndreas Bonertz, Vera Mahler, Stefan Vieths
Allergy|December 29, 2022
Introduction of General Chapters on standard methods for allergen quantification in the European PharmacopoeiaJulia Zimmer, Andreas Bonertz, Susanne Kaul, et al.
British Journal of Clinical Pharmacology|March 25, 2025
European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populationsAndreas Bonertz, Catherine Drai, Thomas Castelnovo, et al.
Allergy|March 1, 2024
Quality control of allergen products with mass spectrometry part I: Positioning within the EU regulatory frameworkJelena Spiric, Thomas Schulenborg, Thomas Holzhauser, et al.
The Journal of Allergy and Clinical Immunology|March 7, 2022
A regulator's view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensureAndreas Bonertz, Anubha Tripathi, Julia Zimmer, et al.
Journal of the National Cancer Institute|July 27, 2007
Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinomaDaniel Nummer, Elisabeth Suri-Payer, Hubertus Schmitz-Winnenthal, et al.
Allergologie Select|December 25, 2023
Allergen-specific immunotherapy and evidence: A European regulatory perspectiveDetlef Bartel, Andreas Bonertz, Diana Hartenstein, et al.
Pageof 3